These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 8411646

  • 21. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
    Biesma B, van de Werf PR, Melissant CF, Brok RG.
    Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
    [Abstract] [Full Text] [Related]

  • 22. [Guidelines for the treatment of anemia in chronic renal failure].
    Triolo G, Italian Society of Nephrology.
    G Ital Nefrol; 2003 Oct; 20 Suppl 24():S61-82. PubMed ID: 14666504
    [Abstract] [Full Text] [Related]

  • 23. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V, Rutkowski B, Baldamus C, Scigalla P, Koytchev R, Epoetin Zeta Study Group.
    Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Erythropoietin treatment of anemia associated with multiple myeloma.
    Ludwig H, Fritz E, Kotzmann H, Höcker P, Gisslinger H, Barnas U.
    N Engl J Med; 1990 Jun 14; 322(24):1693-9. PubMed ID: 2342535
    [Abstract] [Full Text] [Related]

  • 27. Therapy of anemia in patients with multiple myeloma.
    Adam Z, Krahulová M, Spelda S, Vorlícek J, Hejlová N, Hájek R, Tomíska M.
    Acta Med Austriaca; 1995 Jun 14; 22(4):59-64. PubMed ID: 8835422
    [Abstract] [Full Text] [Related]

  • 28. [Erythropoietin alone or as an adjuvant for the autologous blood donation program in major orthopedic surgery].
    Bisbe E, Sáez M, Nomen N, Castillo J, Santiveri X, Mestre C, Cano X.
    Rev Esp Anestesiol Reanim; 2003 Oct 14; 50(8):395-400. PubMed ID: 14601367
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Recombinant human erythropoietin in a patient with multiple myeloma and end-stage renal disease.
    Holley JL, Nolan TA, Piraino B.
    Clin Nephrol; 1992 Mar 14; 37(3):145-7. PubMed ID: 1563119
    [Abstract] [Full Text] [Related]

  • 31. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
    Arenas Gracia M, Abad Gosálvez A, Colomina Avilés J, Pascual Pérez R, Ferriz Moreno P.
    An Med Interna; 1995 Apr 14; 12(4):187-8. PubMed ID: 7620064
    [Abstract] [Full Text] [Related]

  • 32. Is erythropoietin treatment safe and effective in myeloma patients receiving hemodialysis?
    Caillette A, Barreto S, Gimenez E, Labeeuw M, Zech P.
    Clin Nephrol; 1993 Sep 14; 40(3):176-8. PubMed ID: 8403574
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
    Pizzarelli F, David S, Sala P, Icardi A, Casani A.
    Am J Kidney Dis; 2006 Jun 14; 47(6):1027-35. PubMed ID: 16731298
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.